CoChat

STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells

Open access
Babij, Carol, Zhang, Yihong, Kurzeja, Robert J., Munzli, Anke, Shehabeldin, Amro, Fernando, Manory, Quon, Kim, Kassner, Paul D., Ruefli-Brasse, Astrid A., Watson, Vivienne J., Fajardo, Flordeliza, Jackson, Angela, Zondlo, James, Sun, Yu, Ellison, Aaron R., Plewa, Cherylene A., San, Miguel Tisha, Robinson, John, McCarter, John, Schwandner, Ralf, Judd, Ted, Carnahan, Josette, Dussault, Isabelle · 2011 · Cancer Research
Cited by 122

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Despite the prevalence of KRAS mutations in human cancers, there remain no targeted therapies for treatment. The serine–threonine kinase STK33 has been proposed to be required for the survival of mutant KRAS-dependent cell lines, suggesting that small molecule kinase inhibitors of STK33 may be useful to treat KRAS-dependent tumors. In this study, we investigated the role of STK33 in mutant KRAS human cancer cells using RNA interference, dominant mutant overexpression, and small molecule inhibitors. As expected, KRAS downregulation decreased the survival of KRAS-dependent cells. In contrast, STK33 downregulation or dominant mutant overexpression had no effect on KRAS signaling or survival of these cells. Similarly, a synthetic lethal siRNA screen conducted in a broad panel of KRAS wild-type or mutant cells identified KRAS but not STK33 as essential for survival. We also obtained similar negative results using small molecule inhibitors of the STK33 kinase identified by high-throughput screening. Taken together, our findings refute earlier proposals that STK33 inhibition may be a useful therapeutic approach to target human KRAS mutant tumors. Cancer Res; 71(17); 5818–26. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-0778

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 122

Metadata

Authors
Babij, C., Zhang, Y., Kurzeja, R. J., Munzli, A., Shehabeldin, A., Fernando, M., Quon, K., Kassner, P. D., Ruefli-Brasse, A. A., Watson, V. J., Fajardo, F., Jackson, A., Zondlo, J., Sun, Y., Ellison, A. R., Plewa, C. A., San, M. T., Robinson, J., McCarter, J., Schwandner, R., Judd, T., Carnahan, J., & Dussault, I.
Venue
Cancer Research
Published
2011-08-30
Volume
71
Issue
17
Pages
5818-5826
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1984863053
Cited by
122
References
4
FWCI
5.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-0778
The paper
Babij, C., Zhang, Y., Kurzeja, R. J., Munzli, A., Shehabeldin, A., Fernando, M., Quon, K., Kassner, P. D., Ruefli-Brasse, A. A., Watson, V. J., Fajardo, F., Jackson, A., Zondlo, J., Sun, Y., Ellison, A. R., Plewa, C. A., San, M. T., Robinson, J., McCarter, J., . . . Dussault, I. (2011). STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-0778

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.